Next Article in Journal
Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity
Previous Article in Journal
Killing Two Birds with One Stone: Is the COVID-19 Vaccination Campaign an Opportunity to Improve Adherence to Cancer Screening Programmes? The Challenge of a Pilot Project in a Large Local Health Authority in Rome
Previous Article in Special Issue
Knowledge, Attitudes, and Behaviors Regarding Lyme Borreliosis Prevention in the Endemic Area of Northeastern Poland
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Serological Protection Rates against TBEV Infection in Blood Donors from a Highly Endemic Region in Southern Germany

1
Bundeswehr Institute of Microbiology, Neuherbergstraße 11, 80937 München, Germany
2
Parasitology Unit, University of Hohenheim, Emil-Wolff-Straße 34, 70599 Stuttgart, Germany
3
Division of Infectious Diseases, Department of Medicine II, University of Freiburg Medical Center and Faculty of Medicine, 79098 Freiburg, Germany
4
Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Stefan-Meier-Straße 26, 79098 Freiburg, Germany
5
Gesundheitszentrum Oberkirch, Am Marktplatz 8, 77704 Oberkirch, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Vaccines 2023, 11(3), 522; https://doi.org/10.3390/vaccines11030522
Submission received: 22 January 2023 / Revised: 11 February 2023 / Accepted: 15 February 2023 / Published: 23 February 2023

Abstract

Background: Tick-borne encephalitis (TBE) is the most significant tick-borne disease in Europe and Asia, with more than 10,000 cases per year worldwide. A surge of reported TBE cases can be observed despite the availability of highly efficient vaccines. There is little known about the serological immune protection rate of the population in Germany. The seroprotection rate is defined as the presence of neutralizing antibodies. In contrast, the vaccination rate, as defined by public health agencies, may differ from the true protection rate in a population. Materials and Methods: 2220 blood samples from inhabitants of the county Ortenaukreis in the Federal State of Baden-Württemberg in Germany were included in the study. These were tested for anti-TBEV IgG antibodies by an anti-TBEV-IgG-ELISA. Subsequently, all TBEV-IgG positive samples were confirmed for neutralizing antibodies in the micro serum neutralization assay. Results: From the overall 2220 samples, 2104 were included in the comparison because of the selection of specific age groups (ages 20–69). In our sample size, we found an average serological protection rate (presence of neutralizing antibodies) of 57% (518/908) for the female blood donors and of 52% (632/1196) for the male blood donors. Discussion: In this study, we present new findings on a highly endemic region in southern Germany. Additionally, we present current data regarding the serological TBEV protection rates in the Ortenaukreis in southern Germany and compare these with a dataset published by the RKI, which is based on vaccination reports of the primary care providers and health care insurers, and with a self-reporting study conducted by a vaccine manufacturer. Our results significantly exceed the official numbers of average active vaccination status by 23.2% for females and by 21% for males. This might indicate an even longer persistence of TBE-vaccination-induced antibody titers than previously assumed.
Keywords: TBEV; TBE; Germany; epidemiology; vaccines; protection; NS1 TBEV; TBE; Germany; epidemiology; vaccines; protection; NS1

Share and Cite

MDPI and ACS Style

Dobler, G.; Euringer, K.; Kaier, K.; Borde, J.P. Serological Protection Rates against TBEV Infection in Blood Donors from a Highly Endemic Region in Southern Germany. Vaccines 2023, 11, 522. https://doi.org/10.3390/vaccines11030522

AMA Style

Dobler G, Euringer K, Kaier K, Borde JP. Serological Protection Rates against TBEV Infection in Blood Donors from a Highly Endemic Region in Southern Germany. Vaccines. 2023; 11(3):522. https://doi.org/10.3390/vaccines11030522

Chicago/Turabian Style

Dobler, Gerhard, Kathrin Euringer, Klaus Kaier, and Johannes P. Borde. 2023. "Serological Protection Rates against TBEV Infection in Blood Donors from a Highly Endemic Region in Southern Germany" Vaccines 11, no. 3: 522. https://doi.org/10.3390/vaccines11030522

APA Style

Dobler, G., Euringer, K., Kaier, K., & Borde, J. P. (2023). Serological Protection Rates against TBEV Infection in Blood Donors from a Highly Endemic Region in Southern Germany. Vaccines, 11(3), 522. https://doi.org/10.3390/vaccines11030522

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop